ArminLabs is delighted to announce that testing is again available for all US patients from 17th April onwards.
The rough times recently have demanded lots of adjustments and adaptability from all of us. ArminLabs has used this time to apply for and achieve CAP accreditation and CLIA certification.
As a token of our gratitude and excitement going forward, ArminLabs will maintain our past price levels in the US and not increase them.
We will be able to offer sample transport of between 24 and 48 hours from the US back to Germany due to our multiyear, loyal partnership with FedEx, UPS and DHL.
ArminLabs test-kits are free of charge as usual. Start ordering now to be one of the first to join the ArminLabs Relaunch with new testing and therapeutic options. You can send us your address and your phone number and we will just send the kit to you.

Sign up for regular updates on laboratory diagnostic and testing methods at ArminLabs.

We will answer the most frequent questions our team is asked by practitioners and patients. Step by step these will be expanded by webinar videos and other instructional videos.

Please contact us to order a testkit for the blooddraw.
After you've received the testkit we recommend using the internet-based DHL platform mydhl.express.dhl to order a DHL pickup.
If your testkit does not contain a DHL Shipment Waybill, please contact us some days before getting your blood drawn. In this case we will create your DHL Shipment Waybill and email it back, so that you can print it.

Please contact us to order a testkit for the blooddraw.
After you've received the testkit we recommend using the internet-based UPS platform www.ups.com to order a UPS pickup.
If your testkit does not contain a UPS Shipment Waybill, please contact us some days before getting your blood drawn. In this case we will create your UPS Shipment Waybill and email it back, so that you can print it.

The ANA seropositive and seronegative groups were matched for age, sex and ethnicity; the T lymphocyte reactivity to Borrelia burgdorferi sensu stricto (full antigen) in the former group (mean 5.60) was significantly higher than that in the seronegative group (mean 1.81; p < 0.05).

The COVID-19 Symptomchecklist is a supportive tool in the clinical diagnosis of the practitioner/therapist. It does not replace a detailed clinical diagnosis.

1. Completing the COVID-19 Symptom Checklist for:
   • Patients who have previously tested positive via a swab test,
   • Patients with previous typical COVID-19 symptoms,
   • People from risk-groups with previous contact with persons infected with the COVID-19 virus,
   • 2 - 3 weeks after onset of symptoms or 4 -5 weeks after exposure!
2. If a past infection is suspected, run the SARS-CoV2 IgG/IgA ELISA antibody test in the laboratory or the SARS-CoV2 IgG/IgM rapid test (in the laboratory or clinic, using serum), to check the patient’s immune response
3. Interpretation of the antibody results by medical professional with the patient or subject (e.g. whether the infection has already taken place or a possible immunity)